1Department of Dermatology, The 901th Hospital of the Joint Logistics Support Force of Chinese People′s Liberation Army, Anhui Medical University, Hefei 230031, China; 2Department of Pathophysiology and High Altitude Pathology, Army Medical University, Chongqing 400038, China
National Natural Science Foundation of China (81502728); Major Project of Medical Science and Technology Innovation in Nanjing Military Region in 2013 (ZX10)
Zhong Zhiting, Miao Qingqing, Jiang Zhuyan, Zhang Mengjie, Tang Jun. Translation of circ-PTPN22 in peripheral blood mononuclear cells of patients with systemic lupus erythematosus and its significance[J]. Chinese Journal of Dermatology, 2020, 53(7): 525-532.doi:10.35541/cjd.20200195
Kristensen LS, Andersen MS, Stagsted L, et al. The biogenesis, biology and characterization of circular RNAs[J]. Nat Rev Genet, 2019,20(11):675⁃691. doi: 10.1038/s41576⁃019⁃0158⁃7.
[2]
Hansen TB, Jensen TI, Clausen BH, et al. Natural RNA circles function as efficient microRNA sponges[J]. Nature, 2013,495(7441):384⁃388. doi: 10.1038/nature11993.
[3]
Li Z, Huang C, Bao C, et al. Exon⁃intron circular RNAs regulate transcription in the nucleus[J]. Nat Struct Mol Biol, 2015,22(3):256⁃264. doi: 10.1038/nsmb.2959.
[4]
Abdelmohsen K, Panda AC, Munk R, et al. Identification of HuR target circular RNAs uncovers suppression of PABPN1 translation by CircPABPN1[J]. RNA Biol, 2017,14(3):361⁃369. doi: 10.1080/15476286.2017.1279788.
[5]
Yang Y, Gao X, Zhang M, et al. Novel role of FBXW7 circular RNA in repressing glioma tumorigenesis[J]. J Natl Cancer Inst, 2018,110(3):304⁃315. doi: 10.1093/jnci/djx166.
[6]
Miao Q, Zhong Z, Jiang Z, et al. RNA⁃seq of circular RNAs identified circPTPN22 as a potential new activity indicator in systemic lupus erythematosus[J]. Lupus, 2019,28(4):520⁃528. doi: 10.1177/0961203319830493.
[7]
Zhang M, Huang N, Yang X, et al. A novel protein encoded by the circular form of the SHPRH gene suppresses glioma tumorigenesis[J]. Oncogene, 2018,37(13):1805⁃1814. doi: 10. 1038/s41388⁃017⁃0019⁃9.
[8]
Yang L, Xu LZ, Liu ZQ, et al. Interleukin⁃13 interferes with activation⁃induced t⁃cell apoptosis by repressing p53 expression[J]. Cell Mol Immunol, 2016,13(5):669⁃677. doi: 10.1038/cmi. 2015.50.
[9]
Bottini N, Peterson EJ. Tyrosine phosphatase PTPN22: multifunctional regulator of immune signaling, development, and disease[J]. Annu Rev Immunol, 2014,32:83⁃119. doi: 10.1146/annurev⁃immunol⁃032713⁃120249.
[10]
Hamza RT, Awwad KS, Temsah KA, et al. R620W polymorphism of protein tyrosine phosphatase PTPN22 in Egyptian children and adolescents with systemic lupus erythematosus: relation to thyroid autoimmunity[J]. Int J Adolesc Med Health, 2013,25(2):143⁃149. doi: 10.1515/ijamh⁃2013⁃0022.
[11]
Carmona FD, Martín J. The potential of PTPN22 as a therapeutic target for rheumatoid arthritis[J]. Expert Opin Ther Targets, 2018,22(10):879⁃891. doi: 10.1080/14728222.2018.1526924.
[12]
Crow MK. Type I interferon in the pathogenesis of lupus[J]. J Immunol, 2014,192(12):5459⁃5468. doi: 10.4049/jimmunol.100 2795.
[13]
Wang Y, Ewart D, Crabtree JN, et al. PTPN22 variant R620W is associated with reduced toll⁃like receptor 7⁃induced type I interferon in systemic lupus erythematosus[J]. Arthritis Rheumatol, 2015,67(9):2403⁃2414. doi: 10.1002/art.39211.